67 related articles for article (PubMed ID: 9307193)
1. Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank.
Wu Z; Trabert B; Guillemette C; Caron P; Bradwin G; Graubard BI; Weiderpass E; Ursin G; Langseth H; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1564-1571. PubMed ID: 37619591
[TBL] [Abstract][Full Text] [Related]
2. Domestic use of pesticides during early periods of development and risk of testicular germ cell tumors in adulthood: a French nationwide case-control study.
Danjou AMN; Pérol O; Coste A; Faure E; Béranger R; Boyle H; Belladame E; Grassot L; Dubuis M; Spinosi J; Bouaoun L; Fléchon A; Bujan L; Drouineaud V; Eustache F; Berthaut I; Perrin J; Brugnon F; Charbotel B; Schüz J; Fervers B;
Environ Health; 2021 Oct; 20(1):111. PubMed ID: 34706722
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer risk among testicular germ-cell cancer survivors: a systematic review and meta-analysis.
Reiter O; Voss VB; Fluss R; Boyce LM; DeFazio JL; Halpern AC; Marghoob AA
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1025-1033. PubMed ID: 35034398
[TBL] [Abstract][Full Text] [Related]
4. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the treatment challenges in men with intellectual difficulties and testicular cancer as seen in Down syndrome: single centre experience.
Hafeez S; Singhera M; Huddart R
BMC Med; 2015 Jun; 13():152. PubMed ID: 26123546
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.
Furuya A; Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(1):438-42. PubMed ID: 24427369
[TBL] [Abstract][Full Text] [Related]
7. Posterior fossa immature teratoma in an infant with trisomy 21: A case report and review of the literature.
Bakhtiar Y; Yonezawa H; Bohara M; Hanaya R; Okamoto Y; Sugiyama K; Yoshioka T; Arita K
Surg Neurol Int; 2012; 3():100. PubMed ID: 23061016
[TBL] [Abstract][Full Text] [Related]
8. Developmental exposures of male rats to soy isoflavones impact Leydig cell differentiation.
Sherrill JD; Sparks M; Dennis J; Mansour M; Kemppainen BW; Bartol FF; Morrison EE; Akingbemi BT
Biol Reprod; 2010 Sep; 83(3):488-501. PubMed ID: 20554919
[TBL] [Abstract][Full Text] [Related]
9. Etiologic factors in testicular germ-cell tumors.
McGlynn KA; Cook MB
Future Oncol; 2009 Nov; 5(9):1389-402. PubMed ID: 19903067
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic aspects of testicular germ cell tumours.
Lutke Holzik MF; Sijmons RH; Hoekstra-Weebers JE; Sleijfer DT; Hoekstra HJ
Hered Cancer Clin Pract; 2008 Feb; 6(1):3-14. PubMed ID: 19715611
[TBL] [Abstract][Full Text] [Related]
11. Constitutional aneuploidy and cancer predisposition.
Ganmore I; Smooha G; Izraeli S
Hum Mol Genet; 2009 Apr; 18(R1):R84-93. PubMed ID: 19297405
[TBL] [Abstract][Full Text] [Related]
12. Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.
Aguilar-Ponce JL; Vidal-Millán S; Molina-Calzada C; Chilaca-Rosas F; Martínez-Cedillo J; Cruz-López JC
Clin Transl Oncol; 2008 Nov; 10(11):768-71. PubMed ID: 19015076
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the inhibin pathway and risk of testicular germ cell tumors.
Purdue MP; Graubard BI; Chanock SJ; Rubertone MV; Erickson RL; McGlynn KA
Cancer Res; 2008 Apr; 68(8):3043-8. PubMed ID: 18413775
[TBL] [Abstract][Full Text] [Related]
14. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2.
Laffin B; Wellberg E; Kwak HI; Burghardt RC; Metz RP; Gustafson T; Schedin P; Porter WW
Mol Cell Biol; 2008 Mar; 28(6):1936-46. PubMed ID: 18160708
[TBL] [Abstract][Full Text] [Related]
15. Clinical epidemiology of testicular germ cell tumors.
Dieckmann KP; Pichlmeier U
World J Urol; 2004 Apr; 22(1):2-14. PubMed ID: 15034740
[TBL] [Abstract][Full Text] [Related]
16. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.
DeYoung MP; Tress M; Narayanan R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4760-5. PubMed ID: 12676991
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of patients with testicular germ cell cancer.
Hartmann JT; Kanz L; Bokemeyer C
Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
[TBL] [Abstract][Full Text] [Related]
18. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature.
Satgé D; Sasco AJ; Curé H; Leduc B; Sommelet D; Vekemans MJ
Cancer; 1997 Sep; 80(5):929-35. PubMed ID: 9307193
[TBL] [Abstract][Full Text] [Related]
19. Testicular seminoma and Down's syndrome.
Roberge D; Souhami L; Laplante M
Can J Urol; 2001 Feb; 8(1):1203-6. PubMed ID: 11268309
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
